Spots Global Cancer Trial Database for Platelet Modulation: A Study of Angiogenic and Coagulation Proteins in Patients With Cancer
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Platelet Modulation: A Study of Angiogenic and Coagulation Proteins in Patients With Cancer
Official Title: Platelet Modulation in the Control of Angiogenesis: A Study of Angiogenic and Coagulation Proteins in Patients With Cancer
Study ID: NCT01148407
Conditions
Interventions
Study Description
Brief Summary: Blood samples on persons with cancer will be sampled for angiogenic, metastatic and coagulation proteins.
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
University of Vermont/Fletcher Allen Health Care, Burlington, Vermont, United States
Contact Details
Name: Chris E Holmes, MD PhD
Affiliation: University of Vermont
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
